Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belumosudil tablets in Chinese adolescents with chronic graft-versus-host disease with inadequate response to corticosteroids or other systemic therapy
CTR20243563Phase 4Completed
- Sponsor
- Kadmon
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of belumosudil in chronic graft-versus-host disease (cGVHD), sponsored by Kadmon. Started Dec 2024; status: completed.
02
Drugs
belumosudil
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on CTR20243563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243563.